Edesa Biotech is trading 5.5% down at $6.24 following recent volatility and a prior after-hours rebound.
- There are no new company-specific headlines or filings today to explain the downward move.
- The price action appears driven by the stock's typical low-liquidity and high-volatility trading dynamics rather than fresh fundamental news.